Skip Nav Destination
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1–positive BCP-ALL beyond kinase domain mutations
Incidence and risk factors of pain crisis after hematopoietic cell transplantation for sickle cell disease
A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome
Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features
Monocytes in leukapheresis products affect the outcome of CD19–targeted CAR T-cell therapy in patients with lymphoma
